Learn More
Medchemexpress LLC Ensitrelvir fumarate | 2757470-18-9 | 99.99% | C26H21ClF3N9O6 | 100 MG

Supplier: Medchemexpress LLC HY143216A100MG
Ensitrelvir fumarate (S-217622) is the first orally active non-covalent, non-peptidic SARS-CoV-2 3CL protease inhibitor with an IC50 of 13 nM. It demonstrates EC50 values of approximately 0.4 μM against wild-type SARS-CoV-2 and its Alpha, Beta, Gamma, and Delta variants in cytopathic effect (cpe)-inhibition assays. This compound also dose-dependently inhibits the intrapulmonary replication of SARS-CoV-2 in mice and shows activity against SARS-CoV and MERS-CoV.
- Orally active non-covalent, non-peptidic SARS-CoV-2 3CL protease inhibitor.
- Inhibits wild-type SARS-CoV-2 and Alpha, Beta, Gamma, and Delta variants.
- Inhibits intrapulmonary replication of SARS-CoV-2 in mice.
- Exhibits activity against SARS-CoV and MERS-CoV.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.